Swedish Orphan Biovitrum AB Financial Overview
Swedish Orphan Biovitrum AB's market cap is currently kr112.50B. The company's EPS TTM is kr-8.32; its P/E ratio is 4,553.37; Swedish Orphan Biovitrum AB is scheduled to report earnings on October 20, 2025, and the estimated EPS forecast is kr3.88. See an overview of income statement, balance sheet, and cash flow financials.
